Synchrony Financial issues private-label and co-branded credit cards on behalf of retail, healthcare, and other partners. Retailers, e-commerce platforms, and healthcare providers embed Synchrony's financing into their checkout experience; consumers use the cards to make purchases, often with promotional financing terms. Synchrony earns money primarily through interest charges on revolving card balances, along with merchant fees. Its three main businesses are store credit cards (e.g., partner-branded retail cards), installment financing for big-ticket purchases, and CareCredit, which covers elective medical and dental procedures.
Employees20,000IPOJan 18, 2018SIC6159HQ777 Long Ridge Road, Stamford, CT, USA, 06902
to
Financials
Profitability
Metric
Current
Margins
Gross Margin
—
Operating Margin
—
EBITDA Margin
—
Net Margin
23.4%
OCF Margin
64.5%
FCF Margin
64.5%
Returns on Capital
ROE
20.9%
ROA
2.9%
ROIC
—
ROCE
0.0%
ROC (Greenblatt)
0.0%
3Y ROIIC
0.0%
Consistency
Years Profitable / 10Y
10
Valuation
Metric
Current
Earnings Multiples
P/E (TTM)
7.59
Forward P/E
7.75
P/E ex-NRI
7.59
Shiller P/E (CAPE)
11.30
Cash Flow Multiples
P/FCF
2.69
P/OCF
2.69
P/Owner Earnings
—
FCF Yield
40.18%
Enterprise Value Multiples
EV / EBIT
—
EV / Forward EBIT
—
EV / EBITDA
—
EV / Forward EBITDA
—
EV / Revenue
1.84
EV / Forward Revenue
2.49
Asset / Sales
P/S
1.73
P/B
1.58
P/Tangible Book
1.76
Growth-Adjusted
PEG
0.44
Capital Returns
Metric
Current
Dividends
Dividend Yield (TTM)
1.67%
Forward Dividend Yield
1.84%
3Y Dividend Growth
8.5%
Payout Ratio
0.12
5Y Yield on Cost
2.04%
Buybacks & Dilution
3Y Buyback Ratio
7.40%
Combined
Shareholder Yield
18.33%
Balance Sheet
Metric
Current
Leverage
Debt / Equity
0.97
Gross Debt / EBITDA
—
Cash / Debt
0.99
Equity / Assets
0.14
Coverage
Interest Coverage
—
Short-Term Liquidity
Current Ratio
0.00
Quick Ratio
0.00
Cash Ratio
0.00
Composite Scores
Piotroski F-Score
6
Altman Z-Score
—
Split History
Date
Split
No split history found.
Ex-date
Amount
Pay date
2026-08-05
$0.34
2026-08-17
2026-05-05
$0.3
2026-05-15
2026-02-06
$0.3
2026-02-17
2025-11-05
$0.3
2025-11-17
2025-08-05
$0.3
2025-08-15
2025-05-06
$0.3
2025-05-15
2025-02-03
$0.25
2025-02-18
2024-11-04
$0.25
2024-11-15
2024-08-05
$0.25
2024-08-15
2024-05-03
$0.25
2024-05-15
10 of 35
View allDate
Transcript
Type
2026-06-24
Synchrony Financial Annual Shareholders Meeting Transcript
Shareholders and Annual Meetings
2026-06-09
Synchrony Financial at Morgan Stanley US Financials Conference Transcript
Conference Presentations
2026-04-21
Q1 2026 Synchrony Financial Earnings Call Transcript
Earnings Call
2026-03-10
Synchrony Financial at RBC Capital Markets Global Financial Institutions Conference Transcript
Conference Presentations
2026-01-27
Q4 2025 Synchrony Financial Earnings Call Transcript
Earnings Call
2025-12-09
Synchrony Financial at Goldman Sachs U.S. Financial Services Conference Transcript
Conference Presentations
2025-10-15
Q3 2025 Synchrony Financial Earnings Call Transcript
Earnings Call
2025-07-22
Q2 2025 Synchrony Financial Earnings Call Transcript
Earnings Call
2025-04-22
Q1 2025 Synchrony Financial Earnings Call Transcript
Earnings Call
2025-01-28
Q4 2024 Synchrony Financial Earnings Call Transcript
Earnings Call
10 of 64
5-Step DuPont Analysis
ROE %
20.79%
×
×
Net Margin %
23.40%
×
×
Operating Margin %
—
Operating Income
—
÷
Revenue
$15.03B
×
Tax Burden
0.7625
Net Income
$3.52B
÷
Pretax Income
$4.61B
×
Interest Burden
—
Pretax Income
$4.61B
÷
Operating Income
—
×
Asset Turnover
0.12
÷
Revenue
$15.03B
÷
Average Total Assets
$121.22B
Begin Total Assets
$120.50B
End Total Assets
$121.93B
×
Equity Multiplier
7.16
÷
Avg Total Assets
$121.22B
÷
Avg Stockholders Equity
$16.92B
Begin Equity
$16.95B
End Equity
$16.90B